Nexentis Technologies (NXTS) Gross Margin (2019 - 2025)
Nexentis Technologies (NXTS) reported Gross Margin of 78.79% for Q1 2025, up 42.42 percentage points from 36.36% a year earlier and up 17.79 percentage points from the prior quarter.
Powered by 
Analysis
Nexentis Technologies (NXTS) Gross Margin (2019 - 2025) Analysis & Trends
For FY2024, Nexentis Technologies posted Gross Margin of 21.43%, down 57.66 percentage points from FY2023.
- Gross Margin has a five-year change of +3.64 percentage points (FY2019 to FY2024).
- By year, Gross Margin came in at 79.09% in FY2023 (+19.27 pp), 59.82% in FY2022 (-9.15 pp), 68.97% in FY2021 (-12.34 pp) and 81.31% in FY2020 (+63.53 pp).
- The Q1 2025 figure ranks as the highest quarterly Gross Margin since Q4 2023.
- Year over year, Gross Margin gained in three of the last six quarters, with an average year-over-year change of +2.82 percentage points.
- The high point for year-over-year Gross Margin in five years was Q4 2020 (a gain of 88.25 percentage points); the low point was Q4 2024 (a drop of 53.46 percentage points).
- Per Business Quant data, the three quarters before Q1 2025 came in at 60.99% (Q4 2024), -755.56% (Q3 2024) and 64.71% (Q2 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 68.19% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 74.74% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 73.54% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 78.02% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 83.60% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 72.04% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 79.76% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 72.78% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 85.33% |
| 10 | Nexentis Technologies | 1.20 Mn | -21.57 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | 78.79% |
| Dec 31, 2024 | 60.99% |
| Sep 30, 2024 | -755.56% |
| Jun 30, 2024 | 64.71% |
| Mar 31, 2024 | 36.36% |
| Dec 31, 2023 | 114.45% |
| Jun 30, 2023 | 26.23% |
| Mar 31, 2023 | 64.68% |
| Dec 31, 2022 | 64.71% |
| Sep 30, 2022 | 52.37% |
| Jun 30, 2022 | 58.18% |
| Mar 31, 2022 | 52.24% |
| Dec 31, 2021 | 64.07% |
| Sep 30, 2021 | 24.83% |
| Jun 30, 2021 | 79.13% |
| Mar 31, 2021 | 97.62% |
| Dec 31, 2020 | 89.50% |
| Mar 31, 2020 | 67.32% |
| Dec 31, 2019 | 1.25% |
| Mar 31, 2019 | 73.76% |
API Access
Nexentis Technologies Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=NXTS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "NXTS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=NXTS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();